Home » Sanofi-Aventis Extends Offer for Genzyme
Sanofi-Aventis Extends Offer for Genzyme
France’s Sanofi-Aventis says it has extended its $18.5 billion takeover offer for U.S.-based biotech drugmaker Genzyme Corp.
StarTribune
StarTribune
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May